Guangzhou Bio-gene Technology Co., Ltd is a Chinese biotechnology company based in Guangzhou city, Guangdong Province, specializing in the discovery, development and delivery of novel cell therapies for the treatment of blood and solid tumors, and auto-immune diseases.

We have established our own product pipeline, including a variety of chimeric antigen receptor T cell products, such as novel target CAR-T (CLL-1 CAR-T， GPRC5D CAR-T) and universal CAR-T (Gamma-delta CAR-T) for various targets.

We have built a in-house GMP facility in Science City of Guangzhou, and have developed a full research and development platform from antibody screening, lentiviral vector and CAR-T cell GMP manufacturing to clinical trial.